Chimeron Bio Corp is a forward-thinking biotechnology company headquartered in Philadelphia, focused on the innovation of RNA-based therapeutics and vaccines. Through its proprietary ChaESAR™ platform, the company seeks to enhance the effectiveness of RNA medicines by leveraging self-amplifying RNA technology to create treatments that are more potent and long-lasting than traditional mRNA solutions.
Company Values
Chimeron Bio stands out with its ChaESAR™ platform, which significantly improves the potency and duration of RNA-based therapies while simplifying the manufacturing process.